The choice of antimicrobial therapy for infective endocarditis in the conditions of gram-positive microorganism dominance in the etiological structure in the russian federation
https://doi.org/10.37489/0235-2990-2021-66-5-6-30-34
Abstract
The problem of infectious endocarditis currently deserves special attention. According to the data, intrahospital mortality caused by this pathology reaches 20%, which is largely due to the development of potential complications, the most common among which are the development and progression of heart failure, as well as thromboembolic manifestations with the damage to target organs of various localization. The article presents the results of a multicenter study establishing the features of antimicrobial therapy in patients with infectious endocarditis under the conditions of the dominance of gram-positive microorganisms in the etiological structure in the Russian Federation. 440 cases of definite and probable infectious endocarditis in the period from September 2006 to December 2020 were analyzed.
About the Authors
A. I. Danilov
Smolensk State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Andrey I. Danilov — Ph. D. in medicine
Smolensk
R. S. Kozlov
Smolensk State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Roman S. Kozlov — D. Sc. in medicine, Corresponding Member of the Russian Academy of Sciences
Smolensk
A. V. Evseev
Smolensk State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Andrey V. Evseev — D. Sc. in medicine, Professor
Smolensk
L. L. Lyamets
Smolensk State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Leonid L. Lyamets — Ph. D. in technical sciences, Associate Professor
Smolensk
References
1. Danilov A.I., Kozlov R.S., Kozlov S.N., Decnich A.V. Praktika vedeniya pacientov s infekcionym ehndokarditom v Rossijskoj Federacii. Antibiotiki i Khimioterapiya. 2017; 62 (1–2): 30–34. (in Russian)
2. Erichsen P., Gislason G.H., Bruun N.E. The increasing incidence of infective endocarditis in Denmark, 1994–2011. Eur J Inter Med. 2016; 35: 95–99.
3. Dayer M.J., Jones S., Prendergast B., Baddour L.M., Lockhart P.B., Thorn-hill M.H. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2015; 385: 1219–1228.
4. Habib G., Lancellotti P., Antunes M.J., Bongiorni M.G., Casalta J.P., Del Zotti F. et. al. 2015 ESC Guidelines for the management of infecive endocarditis: The Task Force for the Management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for C1ardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Hear. J2015; 36 (44): 3075–3128.
5. Gusmanov D.S. Infekcionnyj endokardit u in"ekcionnyh narko-manov. Byulleten' NCSSKHim. A.N. Bakuleva RAMN. 14 (1): 18–25 (in Russian).
6. Danilov A.I., Alekseeva I.V., Asner T.V., Vlasova E.E., Danilova E.M., Dehnich A.V. i soavt. Jetiologija infekcionnogo jendokardita v Rossii. Klin Mikrobiol Antimikrob Khimioter. 2015; 17 (1): 4–10. (in Russian)
7. Danilov A.I., Kozlov R.S., Lyamets L.L. Struktura faktorov riska infekcionnogo endokardita v Rossijskoj Federacii. Vestnik SGMA. 2018; 17 (4): 107–111. (in Russian)
8. Durack D.T., Lukes A.S., Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994; 96 (3): 200–209.
9. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler V.G., Ryan T. at al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000; 30 (4): 633–638.
10. Cancan Gursul N., Vardar I., Demirdal T., Gursul E., Ural S., Yesil M. Clinical and microbiological findings of infective endocarditis. J Infect Develop Countr. 2016; 10 (5): 478–487.
11. Danilov A.I., Kozlov S.N. Obshchie principy vedeniya pacientov s infekcionnym endokarditom. Klinicheskaya Farmakologiya i Terapiya. 2019; 28 (2): 57–60.
12. Gould I.M., Miro J.M., Rybak M.J. Daptomycin: the role of high-dose and combination therapy for Gram-positive infections. Intern J Antimicrob Agents. 2013; 42(3): 202–210.
13. Moiseev V.S., Kotova E.O., Karaulova Ju.L. Jepidemiologija i klinicheskoe techenie sovremennogo infekcionnogo jendokardita (po dannym municipal'noj bol'nicy). Klinicheskaya Farmakologiya i Terapiya. 2014; 23 (3): 62–66. (in Russian)
Review
For citations:
Danilov A.I., Kozlov R.S., Evseev A.V., Lyamets L.L. The choice of antimicrobial therapy for infective endocarditis in the conditions of gram-positive microorganism dominance in the etiological structure in the russian federation. Antibiot Khimioter = Antibiotics and Chemotherapy. 2021;66(5-6):30-34. (In Russ.) https://doi.org/10.37489/0235-2990-2021-66-5-6-30-34
Views:
507
Email this article 